ACVA vs. HQY, MEDP, BILI, WPP, LYFT, AMTM, MARA, SEZL, ETSY, and WSC
Should you be buying ACV Auctions stock or one of its competitors? The main competitors of ACV Auctions include HealthEquity (HQY), Medpace (MEDP), Bilibili (BILI), WPP (WPP), Lyft (LYFT), Amentum (AMTM), Marathon Digital (MARA), Sezzle (SEZL), Etsy (ETSY), and WillScot (WSC). These companies are all part of the "business services" industry.
ACV Auctions vs. Its Competitors
ACV Auctions (NASDAQ:ACVA) and HealthEquity (NASDAQ:HQY) are both mid-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.
HealthEquity has a net margin of 9.80% compared to ACV Auctions' net margin of -12.51%. HealthEquity's return on equity of 11.01% beat ACV Auctions' return on equity.
HealthEquity has higher revenue and earnings than ACV Auctions. ACV Auctions is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
ACV Auctions currently has a consensus price target of $22.68, suggesting a potential upside of 37.34%. HealthEquity has a consensus price target of $118.09, suggesting a potential upside of 18.62%. Given ACV Auctions' higher probable upside, equities analysts clearly believe ACV Auctions is more favorable than HealthEquity.
In the previous week, HealthEquity had 6 more articles in the media than ACV Auctions. MarketBeat recorded 11 mentions for HealthEquity and 5 mentions for ACV Auctions. HealthEquity's average media sentiment score of 0.91 beat ACV Auctions' score of 0.69 indicating that HealthEquity is being referred to more favorably in the news media.
ACV Auctions has a beta of 1.71, meaning that its share price is 71% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500.
88.6% of ACV Auctions shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 2.9% of ACV Auctions shares are held by company insiders. Comparatively, 1.5% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
HealthEquity beats ACV Auctions on 13 of the 16 factors compared between the two stocks.
Get ACV Auctions News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ACVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ACV Auctions Competitors List
Related Companies and Tools
This page (NASDAQ:ACVA) was last updated on 7/5/2025 by MarketBeat.com Staff
